Biotechnology Startups

Aer Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative therapies targeting mucus-related issues in lung diseases. The company's primary focus is on creating inhalable treatments to address airway mucus plugs, which are common in conditions like COPD and asthma.

Akadeum Life Sciences, Inc. is a biotechnology company that specializes in innovative cell separation technologies tailored for the life sciences industry. Its mission is to enhance the efficiency and scalability of vital sample preparation processes essential for research, diagnostics, and cell therapy applications.

Allay Therapeutics is a pioneering company dedicated to transforming post-surgical pain management. By developing innovative solutions that extend localized pain relief for weeks, they aim to reduce opioid use, minimize addiction risks, and lower healthcare costs associated with traditional pain management.

Allyx Therapeutics is a clinical-stage biotechnology company developing disease-modifying oral therapies for neurodegenerative disorders. Its primary focus is on preserving and protecting synapses to slow or reverse the cognitive decline seen in conditions like Alzheimer's and Parkinson's disease. The company's strategy revolves around its lead compound, which targets the underlying cellular pathology of these diseases rather than just managing symptoms.

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

Alzheon, Inc. is a biotechnology company dedicated to developing innovative treatments for Alzheimer's disease. The company focuses on creating therapeutics that aim to slow or halt the progression of Alzheimer's and potentially prevent the onset of clinical symptoms.

Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies. Their primary strategy is to overcome immune system suppression within the tumor microenvironment by targeting and depleting polyamines, thereby enabling the body's own immune system to attack cancer cells.

Antares Therapeutics, Inc. is a leading specialty pharmaceutical company focused on the creation and commercialization of innovative drug delivery technologies. With a mission to enhance patient experiences associated with injectable medications, the company develops solutions that significantly improve comfort and convenience for individuals requiring regular treatment.

Founded 2025

ARC Medical Inc. is a clinical-stage therapeutics company dedicated to developing innovative solutions to prevent surgical adhesions, a prevalent complication following various surgical procedures. With a commitment to improving patient outcomes, the company focuses on clinical advancements that mitigate the risks associated with adhesive formations post-surgery.

Aspira Women's Health Inc. is a leading bio-analytical women's health company dedicated to the development of innovative diagnostic tools specifically for gynecologic diseases. With a strong focus on enhancing early detection and risk assessment, particularly for ovarian cancer, Aspira aims to address significant challenges in women's health diagnostics.

Assurtek Surgical, Inc. is a pioneering medical technology company dedicated to developing innovative solutions aimed at improving the safety and efficacy of dental implant surgeries. Leveraging advanced artificial intelligence, their flagship product enhances surgical precision, thereby protecting vital anatomical structures during procedures.

Founded 2023

Atomwise Inc. is a pioneering technology-enabled pharmaceutical company that employs artificial intelligence to transform the landscape of small molecule drug discovery. By leveraging advanced machine learning techniques, Atomwise aims to streamline the drug development process, making it not only more efficient but also more effective in identifying viable therapeutic candidates.

Aufbau Holdings Ltd. is a biotechnology company focused on creating innovative diagnostic and therapeutic platforms for cancer, ophthalmic diseases, and other medical conditions. Founded in Dublin, Ireland, in March 2019, the company aims to improve patient outcomes by addressing gaps in diagnostic accuracy and treatment efficacy.

Autonomy Bio Inc. is an innovative biotechnology firm focused on advancing RNA-based therapeutics specifically designed to address challenging diseases, with a strong emphasis on oncology and infectious diseases. Leveraging proprietary technology, the company is committed to enhancing the precision and effectiveness of treatments to improve patient outcomes for complex conditions.

Founded 2024

Bariendo Inc. is a pioneering healthcare company based in San Francisco, California, that specializes in innovative, non-surgical weight loss solutions aimed at combating obesity and related metabolic conditions. Committed to enhancing accessibility, Bariendo offers cutting-edge treatments that enable patients to achieve sustainable weight loss without the risks associated with traditional bariatric surgeries.

Founded 2023

Biolinq Inc. is a pioneering healthcare technology company focused on enhancing metabolic health monitoring through innovative wearable biosensors. The company's flagship product, a continuous glucose monitoring (CGM) system, aims to provide a simpler and more accessible alternative to traditional glucose monitoring solutions, significantly improving the lives of people with diabetes.

BioMark Diagnostics Inc. is dedicated to tackling the critical global issue of early cancer detection, particularly focusing on cancers that are notoriously difficult to diagnose, such as lung, breast, and pancreatic cancers. Their diagnostic solutions aim to significantly improve patient outcomes through earlier and more accurate detection, which is essential for effective treatment and increased survival rates.

BioPhoundry, Inc. is a pioneering biotechnology company that specializes in the development of advanced bioengineering solutions to address complex biological challenges. They are committed to driving innovation in the biotechnology sector through robust research and cutting-edge technology.

Founded 2024

Blue Water Biotechnology Engineering (Macau) Co., Ltd is a biotechnology firm dedicated to developing innovative solutions aimed at addressing the pressing issues of water treatment and environmental protection. The company focuses on creating advanced technologies to tackle water pollution and scarcity, offering a range of products and services designed for efficient water and wastewater management.

Founded 2024

BobcatBio, Inc. is an innovative biotechnology company dedicated to developing advanced cancer therapies that specifically target malignant cells while protecting healthy tissue. Focused on harnessing cutting-edge immunotherapeutic techniques, the company is committed to revolutionizing cancer treatment by creating more effective and less toxic options for patients.

Founded 2020

Capsulomics, Inc., now known as Previse, is a pioneering medical diagnostics company dedicated to the early detection and prevention of esophageal cancer. The firm leverages cutting-edge molecular testing to empower gastroenterologists with critical insights into patient risk profiles for more informed treatment options.

CardioMech AS is a Norwegian medical device company dedicated to innovating minimally invasive solutions for structural heart disease, particularly degenerative mitral regurgitation (DMR). With a focus on transforming patient care, the company aims to provide effective alternatives to traditional surgery for this common and serious heart condition.

Carna Biosciences, Inc. is a biotechnology company dedicated to drug discovery and the development of small molecule drugs. The company aims to address unmet medical needs by offering innovative therapeutic solutions in areas where current treatments are either inadequate or non-existent.

Founded 2021

Celestial Therapeutics Inc. is a biopharmaceutical company dedicated to developing innovative therapies aimed at treating, preventing, and curing infectious diseases, inflammatory conditions, and various forms of cancer. With a strong focus on addressing key unmet medical needs, the company integrates cutting-edge technology into its therapeutic solutions.

Cellular Logistics, Inc. is a biotechnology company operating out of Madison, Wisconsin, focused on pioneering advanced regenerative therapies for patients with various cardiovascular diseases. They aim to repair damaged heart tissue and prevent heart failure, particularly in post-heart attack patients, addressing a critical need in cardiac care.

Centerline Biomedical, Inc. is a medical technology company headquartered in Cleveland, Ohio, that specializes in advanced navigation solutions designed for endovascular procedures. Originating from the Cleveland Clinic, the company is focused on transforming vascular interventions to enhance safety and accuracy for both patients and healthcare providers.

Chimeron Bio Corp is a forward-thinking biotechnology company headquartered in Philadelphia, focused on the innovation of RNA-based therapeutics and vaccines. Through its proprietary ChaESAR™ platform, the company seeks to enhance the effectiveness of RNA medicines by leveraging self-amplifying RNA technology to create treatments that are more potent and long-lasting than traditional mRNA solutions.

ChromaCode, Inc. is a biotechnology firm focused on revolutionizing diagnostic testing through its advanced PCR multiplexing technology solutions, enhancing efficiency and scalability in biomarker detection. By integrating cloud computing with traditional PCR methods, ChromaCode provides healthcare and research institutions with innovative approaches to diagnostic problem-solving.

Cimeio Therapeutics is a pioneering biotechnology company established in 2020, committed to revolutionizing the treatment landscape for hematologic diseases through innovative cell therapies. The company focuses on addressing the limitations posed by traditional hematopoietic stem cell (HSC) transplantation, particularly the challenges of harsh conditioning regimens and restricted eligibility for patients.

Founded 2024

Claris Biotherapeutics, Inc. is a pioneering biotechnology company dedicated to the development of innovative therapies specifically aimed at treating corneal diseases. With a particular focus on neurotrophic keratitis (NK), a rare and debilitating condition that can lead to significant vision loss, Claris is committed to addressing critical unmet medical needs in this niche area of ocular health.

CND Life Sciences, Inc. is a pioneering medical technology company focused on developing diagnostic solutions for neurodegenerative diseases, particularly those related to abnormal protein accumulation in the nervous system. Their innovative approach centers around minimally invasive skin-based diagnostics aimed at improving the accuracy of diagnosing conditions like Parkinson’s disease and related disorders.

Comend Inc. is a technology company that specializes in creating integrated intercom systems and communication solutions aimed at enhancing security and safety in various environments. By unifying communication across multiple platforms, they address the challenges of fragmented communication effectively.

Founded 2023

Consano Bio is an early-stage biotechnology startup founded in 2022 and headquartered in Des Moines, Iowa. The company focuses on developing first-in-category biologic therapeutics to treat painful and debilitating orthopedic conditions. Its core strategy is to target the underlying drivers of disease rather than merely addressing symptoms.

Founded 2022

CoRegen, Inc. is a pioneering biopharmaceutical company dedicated to the development of innovative treatments aimed at aggressive cancers and chronic diseases. Utilizing its proprietary master gene regulator platform, CoRegen works on harnessing the body’s immune system to combat cancer effectively.

Founded 2022

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment through pioneering biologically-based therapies. The company is firmly committed to addressing the pressing challenge of drug resistance in cancer treatment by developing innovative medications that work by reactivating cell death mechanisms.

Cynaptec Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. Their primary emphasis lies in addressing significant unmet medical needs, particularly for conditions that currently lack effective treatments.

Founded 2025

Delphinus Medical Technologies, Inc. is a pioneering medical imaging firm based in Novi, Michigan, dedicated to transforming breast cancer screening, especially for women with dense breast tissue. The company is renowned for developing the SoftVue™ system, which utilizes advanced ultrasound technology to improve cancer detection and streamline the screening process.

DMC Biotechnologies, Inc. is a U.S.-based biomanufacturer dedicated to innovating the chemical industry by utilizing sustainable, bio-based production methods for specialty chemicals. By leveraging advanced techniques such as precision fermentation and synthetic biology, the company aims to manufacture high-quality chemical ingredients while minimizing environmental impact.

Elastrin Therapeutics, Inc. is an innovative biotechnology company dedicated to creating groundbreaking therapies aimed at reversing cardiovascular diseases and reinstating elasticity in damaged tissues and organs. By addressing the genetic and environmental factors leading to the deterioration of elastin, the company seeks to enhance the quality of life for patients suffering from related health issues.

Elixirgen Therapeutics, Inc. is a cutting-edge biotechnology firm dedicated to the development of innovative RNA therapeutics aimed at addressing a broad spectrum of medical challenges. The company is committed to providing treatment solutions for rare diseases, cancer, and aging-related conditions that currently have limited therapeutic options.

Endless Events is a comprehensive event management company specializing in seamless and innovative event experiences across virtual, hybrid, and in-person formats. They expertly simplify the intricate process of event planning, ensuring the creation of engaging and memorable experiences that leave a lasting impression on attendees, enhancing client satisfaction and overall ROI.

Founded 2021

Eonn Corp. appears to be a non-existent entity, but it is possible that the query relates to several similarly named companies providing various services. Notably, E.ON SE is a major player in sustainable energy solutions, while Eon by Bentley Systems focuses on 3D environment software for the media and entertainment sector, alongside a cloud backup management company simply known as Eon.

Founded 2024

Epicore Biosystems, Inc. is a digital health company that develops and markets wearable microfluidic technology for real-time, non-invasive health and wellness monitoring. Their solutions provide insights into hydration, stress, nutrition, and overall physiological state, enabling personalized health management.

Episteme Prognostics, Inc. is a pioneering precision medicine company dedicated to revolutionizing pancreatic cancer diagnosis and treatment. By focusing on the development of groundbreaking diagnostic tests, the company aims to enhance therapeutic decisions, ultimately improving patient outcomes. Their innovative technology leverages epigenetic biomarkers to provide critical insights into treatment responses for patients diagnosed with this challenging disease.

Founded 2021

Ernexa Therapeutics Inc. is a biotechnology company focused on developing cell therapy solutions for advanced cancer and autoimmune diseases. They use induced pluripotent stem cells (iPSCs) to create induced mesenchymal stem cells (iMSCs) with unique targeting capabilities, enabling the creation of scalable, off-the-shelf therapies. This method eliminates the need for patient-specific solutions.

Evofem Biosciences, Inc. is a biopharmaceutical company focused on women's sexual and reproductive health. They develop and commercialize hormone-free, patient-controlled solutions, providing women with greater control over their health choices. The company addresses unmet needs in contraception, vaginal infections, and sexually transmitted infections.

FirstVitals Health and Wellness Inc. is a healthcare service organization based in Honolulu, Hawaii, specializing in chronic care management, remote patient monitoring, and diabetes care. The company aims to improve the quality of life for patients with chronic conditions by providing tools and services that enhance health management, reduce complications, and improve patient engagement.

Founded 2024

Galaxy Diagnostics, Inc. specializes in advanced testing solutions designed to detect elusive flea- and tick-borne pathogens, specifically *Bartonella* species, which are often missed by standard diagnostic methods. By enhancing clinical detection, the company aims to improve patient outcomes and strengthen the connection between human and animal health.

Gliknik Inc. is a pioneering biopharmaceutical company that specializes in the development of innovative biologics aimed at treating cancer and autoimmune disorders. The company's unique approach to drug development sets it apart in the biotech industry, as it seeks to create more effective and accessible alternatives to existing treatments.

Grace Therapeutics, Inc. is a late-stage biopharmaceutical company dedicated to the development of innovative drug delivery technologies aimed at improving treatments for rare and orphan diseases. With a focus on enhancing the performance of existing therapies, the company seeks to expedite the onset of action, augment efficacy, minimize side effects, and provide more user-friendly delivery options for patients.

GT Biopharma, Inc. is a clinical stage biopharmaceutical company dedicated to the advancement of immunotherapy treatments for cancer and other serious diseases. By focusing on the limitations of existing treatments, GT Biopharma aims to provide innovative solutions that are both targeted and effective.

Iantrek, Inc. is a pioneering medical technology company dedicated to enhancing glaucoma treatment through innovative solutions tailored for micro-interventional glaucoma surgery (MIGS). With a focus on addressing the pressing global challenge of glaucoma, a leading cause of irreversible blindness affecting over 75 million people worldwide, Iantrek is committed to improving patient outcomes and surgical precision in eye care.

Illexcor Therapeutics, LLC is a biopharmaceutical company dedicated to innovating treatments for sickle cell disease (SCD). Founded in 2020, the company has a mission to address the urgent unmet medical needs by developing oral therapies that effectively manage SCD on a global level.

Founded 2023

Immunic, Inc. is a late-stage clinical biotechnology company focused on developing novel oral therapies for chronic inflammatory, autoimmune, neurologic, and gastrointestinal diseases. The company's primary focus is on its lead drug candidate, vidofludimus calcium, which is in Phase 3 trials for the treatment of multiple sclerosis. Immunic aims to address unmet needs by targeting mechanisms like Nurr1 activation and DHODH inhibition to offer neuroprotective and anti-inflammatory benefits.

Infinity Bio, Inc. is an innovative biotechnology company focused on providing advanced antibody profiling services. Established in 2023 and headquartered in Baltimore, Maryland, the company utilizes cutting-edge technology developed at Johns Hopkins University to address the complexities of antibody responses within the immune system.

Founded 2023

Intrigue Health, Inc. is a cutting-edge medical technology company based in San Diego, California, dedicated to revolutionizing healthcare through innovative home diagnostics. The company focuses on developing point-of-care testing devices that empower patients to conduct clinical-quality diagnostic tests within the comfort of their own homes, thereby democratizing access to health assessments.

iOncologi, Inc. (iOi) is an innovative biotechnology company dedicated to pioneering novel immunotherapies for the treatment of refractory cancers and infectious diseases. With a strong emphasis on addressing the unmet medical needs of cancer patients who do not respond to existing treatments, iOncologi is at the forefront of transforming cancer therapy through advanced scientific research and development.

IVIEW Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing innovative treatments for ocular diseases. By focusing on unmet medical needs in the ophthalmology sector, the company aims to create effective therapies for conditions including dry eye disease, conjunctivitis, myopia, glaucoma, and presbyopia.

KKR FlowMod Aggregator LLC is a specialized subsidiary of KKR & Co. Inc., a leading global investment firm. The company operates primarily as an investment vehicle that focuses on the flow control and industrial automation sectors, providing essential products and services to support various industrial applications.

Founded 2025

Lapix Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative oral therapeutics that restore immune system function for patients with autoimmune diseases. Through a patient-centric approach, Lapix Therapeutics is pioneering treatments that enhance the body's natural immune tolerance.

Latigo Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of non-opioid pain medicines. Based in Thousand Oaks, CA, the company leverages advanced technologies, including artificial intelligence and machine learning, to create innovative treatments that address the unmet needs in pain management.

Long Bridge Medical, Inc. is a medical device company dedicated to developing innovative solutions specifically aimed at enhancing cardiovascular procedures. With a strong focus on addressing the nuances of coronary artery disease, the company seeks to improve treatment options through advanced catheter-based systems.

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing groundbreaking therapies specifically for chronic rhinosinusitis (CRS), a prevalent inflammatory condition affecting the nasal passages and sinuses. By leveraging innovative technologies, Lyra aims to provide effective solutions for CRS patients who often endure ineffective treatments and potentially invasive surgeries.

Founded 2024

Magnus Medical, Inc. is a pioneering medical device company that specializes in developing advanced neuromodulation technology aimed at addressing major depressive disorder (MDD). With a focus on innovative treatments for those suffering from treatment-resistant depression, Magnus Medical is at the forefront of mental health solutions, utilizing cutting-edge neuroscience to improve patient outcomes.

Founded 2020

MASLOW HEALTH INC. is a registered entity in the health sector, though specific details regarding its products and services are currently not available. The company appears to operate within the health and wellness subsector, focusing on innovative solutions for healthcare challenges. However, without further information, its unique value proposition remains undefined.

Founded 2023

Maxymune Therapeutics, Inc. is a pioneering biopharmaceutical company focused on developing innovative immunotherapies aimed at treating various immune-related diseases. With a commitment to advancing patient care through scientific research and development, Maxymune strives to harness the power of the immune system to improve health outcomes.

Founded 2023

MB Holdings 2025, Inc. is a multinational corporation engaged in a diverse array of operations spanning the oil and gas, oilfield services, engineering, and mining sectors. The company delivers innovative solutions across the entire energy and resources value chain on a global scale.

Medici Therapeutics, Inc. is a biotechnology company focused on developing advanced cancer treatments within the immunotherapy sector. The company's primary focus is on advancing tumor-infiltrating lymphocyte (TIL) therapies by leveraging novel insights into cancer immunology, particularly how cancer cells evade immune responses.

Founded 2021

Medicovestor is an early-stage biopharmaceutical company founded in 2023, focused on developing next-generation antibody-drug conjugate (ADC) platforms. The company aims to create precision medicines for solid tumors like pancreatic and ovarian cancer by overcoming the limitations of existing ADCs, particularly in tumors with low antigen expression.

Montara Therapeutics, Inc. is a preclinical-stage biopharmaceutical company dedicated to the development of innovative therapies for neurological diseases and brain cancers. With a strong emphasis on minimizing peripheral side effects and enhancing the efficacy of treatments, Montara is at the forefront of addressing critical challenges in the neurological therapeutics space.

Founded 2022

MuscleSound, Inc. is a health technology company based in Denver that specializes in non-invasive ultrasound solutions for measuring and analyzing muscle health. Leveraging advanced software, the company provides essential data that helps athletes and healthcare providers optimize performance, prevent injuries, and monitor recovery effectively.

Myrtelle Inc. is a clinical-stage gene therapy company carrying the mission of developing innovative treatments for neurodegenerative diseases that primarily affect myelin and white matter in the brain. With a particular focus on Canavan disease, the company addresses critical gaps in treatment options for rare genetic disorders of the central nervous system, aiming to improve patient outcomes significantly.

Founded 2021

Nanopath Inc is a pioneering molecular diagnostics company headquartered in Cambridge, Massachusetts. The company is dedicated to revolutionizing traditional medical testing approaches, particularly in the domain of women's health, by developing rapid and accurate diagnostic solutions.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing pioneering treatments for central nervous system diseases, focusing primarily on brain cancers such as glioblastoma. The company's innovative approaches seek to overcome the formidable challenge of delivering therapeutics across the blood-brain barrier, which has historically hindered effective treatment options.

Founded 2023

Neurolutions Inc. is a pioneering medical technology company committed to enhancing stroke rehabilitation through innovative solutions. With a focus on improving the quality of life for chronic stroke survivors, the company develops advanced therapeutic devices that utilize cutting-edge technology to facilitate recovery.

Neurotrigger Ltd. specializes in innovative solutions for muscle stimulation and rehabilitation, particularly for patients experiencing facial paralysis and muscle atrophy. With a focus on both temporary and permanent conditions, the company employs advanced technology to restore muscle function and improve quality of life.

Neutrolis Inc. is a clinical-stage biotechnology firm that specializes in developing innovative therapies aimed at autoimmune and inflammatory diseases. The company's unique approach focuses on targeting Neutrophil Extracellular Traps (NETs), which are implicated in tissue damage and chronic inflammation associated with several immune-mediated disorders, such as lupus and dry eye disease, as well as severe complications from conditions like COVID-19.

Newleos Therapeutics, Inc. is a pioneering clinical-stage neuroscience company focused on the innovation of therapies for neuropsychiatric disorders. With a commitment to addressing the pressing unmet needs in mental health, Newleos is dedicated to developing effective tools for anxiety and substance use disorders, impacting millions across the United States.

Founded 2024

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for central nervous system disorders, with a particular focus on suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The company seeks to fulfill significant unmet medical needs within these areas by delivering novel treatment options that promise enhanced efficacy and safety.

NurExone Biologic Inc. is a publicly traded biopharmaceutical company based in Canada, specializing in the development of innovative treatments for neurological injuries, particularly focusing on spinal cord injuries. Their research and products aim to address the significant need for effective recovery solutions for patients suffering from acute spinal cord trauma.

Odyssey Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases. The company's strategy involves targeting upstream signaling nodes in the innate immune system to prevent pathological inflammation before it starts, aiming to induce long-lasting remission for patients.

Founded 2021

Oncocyte Corporation is a leading molecular diagnostics company committed to enhancing patient outcomes through advanced diagnostic testing solutions tailored for oncology and transplant care. By focusing on delivering actionable insights, Oncocyte empowers healthcare professionals to make informed medical decisions critical to patient treatment pathways.

Oncotelic Therapeutics, Inc. is a publicly traded, clinical-stage biotechnology company developing RNA therapeutics and small-molecule drugs for immuno-oncology and virology. The company's primary focus is on advancing its lead candidate, OT-101, which targets the TGF-β pathway to treat solid tumors and severe viral diseases. Oncotelic also leverages a proprietary AI platform to support its research and development efforts.

OraLiva, Inc. is an innovative medical technology company specializing in the development of advanced early detection diagnostics for oral cancer. By leveraging cutting-edge technology, the company aims to address the critical issue of late-stage cancer diagnosis, enhancing patient outcomes through timely intervention.

Outlook Therapeutics is a pioneering biopharmaceutical company specializing in the development and commercialization of ophthalmic medications. The company is committed to addressing significant unmet medical needs in the treatment of retinal diseases through innovative therapeutic solutions.

Pacific Diabetes Technologies, Inc. (PDT) is a pioneering company focused on developing advanced diabetes management devices aimed at streamlining treatment for individuals with insulin-dependent diabetes. Their innovative approach integrates multiple functions into a single device to enhance user experience and improve health outcomes.

Founded 2021

PanTher Therapeutics, Inc. is a clinical-stage oncology company that focuses on revolutionizing cancer treatment through localized therapy. By addressing the inefficiencies of systemic drug delivery, PanTher aims to enhance cancer therapies and minimize side effects for patients.

Parcel Biosciences is a seed-stage biotechnology startup founded in 2023, focused on developing next-generation RNA therapeutics. The company is creating a nanoparticle-free delivery system for mRNA medicines, aiming to overcome the technical limitations of current lipid nanoparticle technologies. This innovative approach is designed to enable targeted delivery of therapeutics to specific cell types, expanding the potential applications of mRNA beyond vaccines.

Founded 2024

PhAST Corp. is a biotechnology company specializing in the transformation of infectious disease diagnostics through innovative rapid diagnostic technology. With a focus on minimizing turnaround times for pathogen detection and testing, PhAST Corp. aims to enhance patient care by enabling timely treatment decisions.

Phio Pharmaceuticals Corp. is a biotechnology company specializing in the development of groundbreaking therapeutics, particularly in the field of immuno-oncology. Utilizing their proprietary technology platform, they focus on addressing unmet medical needs to potentially enhance cancer treatment outcomes.

Pluri Inc. is a forward-thinking biotechnology company focused on developing innovative cell-based products and technologies. By addressing critical challenges in the realms of medicine, food production, and environmental sustainability, Pluri Inc. aims to revolutionize the landscape of regenerative medicine and sustainable agriculture.

Pulmotherapeutics Inc. is a biopharmaceutical company dedicated to creating innovative therapies for respiratory diseases. It focuses on developing advanced treatments for severe pulmonary conditions, making use of cutting-edge technology.

Founded 2024

Rakuten Medical, Inc. is a biotechnology company focused on developing advanced cancer treatments through their innovative photoimmunotherapy technology. Their mission is to provide more precise and effective therapeutic options, specifically targeting cancer cells to minimize collateral damage to healthy tissues.

RCE Technologies, Inc. is a pioneering medical technology company dedicated to revolutionizing the early detection of heart attacks through innovative, non-invasive methods. By leveraging advanced infrared technology and machine learning, the company has developed products designed to significantly improve patient outcomes during critical health episodes.

Resolute Science, Inc. is a biotechnology company dedicated to advancing cancer treatment through innovative therapeutic strategies. The company specializes in addressing the challenges of solid tumor cancers, with a focus on overcoming recurrence and drug resistance.

Founded 2020

Restora Medical, Inc. is an innovative biotechnology company founded in 2023 and based in Irvine, California. The company is dedicated to developing cutting-edge medical technologies and solutions within the healthcare industry, aiming to address significant health-related challenges through novel biological and technological advancements.

Founded 2023

Revi Life Sciences, Inc. is a biotechnology-centric company specializing in innovative solutions that enhance the understanding and modeling of human vascular physiology. Their primary focus is on developing in-vitro models that replicate human vascular systems through engineered micro-environments, facilitating advanced research and development within the life sciences sector.

Founded 2023

RNAV8 Bio, Inc. is an innovative biotechnology company dedicated to enhancing the efficacy of mRNA therapeutics. By harnessing advanced technologies like machine learning and artificial intelligence, RNAV8 aims to revolutionize the field of mRNA-based drug development for a wide array of diseases.

Founded 2022

Scorpius Holdings, Inc. is a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing through its subsidiary, Scorpius BioManufacturing. Based in Morrisville, North Carolina, with facilities in San Antonio, Texas, the company provides comprehensive services including process development and analytical testing to pharmaceutical and biotech companies.

Second Heart Assist, Inc. specializes in the development of advanced medical devices aimed at addressing the needs of patients with sustained cardiac congestion and heart failure. Their innovative solutions focus on enhancing patient mobility and quality of life, offering advanced mechanical circulatory support systems.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and discovering next-generation cancer therapeutics. The company utilizes its proprietary biologics platform to create treatments that selectively target the tumor microenvironment. Its primary goal is to advance its pipeline candidates through clinical trials and eventually commercialize them to treat various forms of cancer.

Surgical Training Simulators, Inc. is dedicated to enhancing surgical education through innovative technology. The company specializes in developing advanced virtual reality surgical simulators that provide a realistic training environment, ensuring that surgical trainees can hone their skills safely and effectively without risking patient safety.

Founded 2024

Surrozen, Inc. is a biotechnology firm headquartered in South San Francisco, California, dedicated to pioneering innovative regenerative medicines through the activation of the Wnt signaling pathway. This critical mechanism serves as a foundation for tissue repair and regeneration, positioning Surrozen at the forefront of advanced therapeutic solutions for diverse medical conditions.

Founded 2021

Syenex, Inc. is at the forefront of biotechnology, specializing in advanced delivery technologies for genetic medicine. The company is dedicated to enhancing the field of cell and gene therapy by providing innovative solutions for both in vivo and ex vivo genetic modifications, thereby amplifying the therapeutic potential and clinical impact of these therapies.

Founded 2022

Syndex Bio is a pioneering biotechnology company dedicated to revolutionizing the pace and depth of biological discovery through the application of advanced technologies. Established in 2022 and located in Cambridge, UK, the company focuses on creating innovative tools designed to enhance research capabilities across various fields in biology and medicine.

Founded 2022

Synlico Inc. is an AI-powered drug discovery company dedicated to transforming traditional approaches in oncology through the development of engineered T cell therapies tailored to combat solid tumors. By harnessing advanced computational techniques, Synlico leads a paradigm shift in understanding and addressing the complexities of cellular behavior in the tumor microenvironment.

Founded 2021

Syntis Bio, Inc. is a pioneering biotechnology company focused on transforming oral therapeutics through innovative solutions targeting the small intestine. By leveraging its proprietary SYNT™ platform, the company enhances the absorption and effectiveness of treatments for prevalent and challenging conditions such as obesity, diabetes, and rare diseases.

Founded 2022

Tectonic Therapeutic, Inc. is a pioneering biotechnology company based in Watertown, Massachusetts, dedicated to the discovery and development of advanced therapeutic proteins and antibodies. The company primarily focuses on harnessing the potential of G-Protein Coupled Receptors (GPCRs), which are integral to numerous biological processes and disease pathways.

Telos Biotech is a biotechnology startup that develops technologies to enhance the manufacturing of cell therapies. The company, launched by Cambrian Bio in 2022, focuses on addressing telomere shortening during cell expansion to improve the function, longevity, and robustness of therapeutic cells used to treat cancer and age-related diseases.

Toby, Inc. is a forward-thinking technology company specializing in innovative software solutions designed to streamline business operations across various industries. The company is committed to enhancing productivity through cutting-edge technology, providing tailored solutions that meet unique business needs.

Founded 2023

Topaz Biosciences, Inc. is a biotechnology company that specializes in developing innovative solutions for skin health, with a strong emphasis on harnessing the potential of the skin microbiome. Established in 2022 and based in Emeryville, California, the company is committed to addressing common skin issues such as eczema and acne through scientifically-backed enzyme technology.

Founded 2022

Vail Scientific, Inc. is an innovative medical technology company dedicated to advancing early sepsis detection through its flagship product, the VSNO™ sepsis screening device. Established in 2015 and located in Minneapolis, Minnesota, the company utilizes cutting-edge technology to enhance patient outcomes in critical care settings.

Vaxess Technologies, Inc. is a pioneering life sciences company focused on the development of innovative vaccine and therapeutic delivery technologies. Their flagship product, the MIMIX™ platform, is a cutting-edge transdermal patch system that aims to make vaccines and therapeutics more effective and accessible, particularly in challenging environments.

Virtual Incision Corporation is a pioneering medical technology firm based in Lincoln, Nebraska, dedicated to enhancing robotic-assisted surgery through innovative miniaturized surgical systems. The company focuses on making advanced surgical robotics more accessible and cost-effective for healthcare providers that may not have the infrastructure for traditional large robotic systems.

Vivace Therapeutics, Inc. is a pioneering biotechnology firm focused on creating innovative cancer treatments that specifically target the Hippo-YAP signaling pathway. The company aims to deliver solutions for cancer patients with limited options, particularly those suffering from challenging malignancies driven by pathway dysregulation.

VoxCell BioInnovation Inc. is a pioneering biotechnology company specializing in innovative solutions to enhance the drug development process, particularly within the oncology sector. By focusing on reducing the high failure rate in drug development, VoxCell aims to streamline preclinical testing and ultimately decrease both time and costs involved.

Founded 2020

VQ Biomedical, Inc. is a pioneering medical device company specializing in advanced healthcare solutions for patients suffering from acute respiratory distress syndrome (ARDS) and other severe lung injuries. By developing innovative technologies, the company aims to improve patient outcomes and enhance the quality of care provided in critical health situations.

Founded 2023

Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.

Zeo ScientifiX, Inc., formerly known as Organicell Regenerative Medicine, Inc., is a publicly traded, clinical-stage biopharmaceutical company. It focuses on researching, developing, and manufacturing biological therapeutics derived from perinatal sources to treat degenerative diseases and support regenerative medicine applications.

Zero Point Five Therapeutics, Inc., also known as ZP5 Therapeutics, is a biotechnology company focused on developing effective treatments for neglected tropical diseases, particularly soil-transmitted helminthiasis (STH). The company aims to create accessible therapies for diseases that disproportionately affect marginalized communities worldwide, addressing a critical health crisis caused by intestinal parasitic infections.

Zucara Therapeutics Inc. is a pioneering life sciences company focused on diabetes treatment, specifically dedicated to developing innovative solutions to combat hypoglycemia in individuals with diabetes. Through advanced therapeutics, Zucara aims to improve the quality of life for those affected by insulin-dependent diabetes by providing preventive measures against the potentially dangerous side effects of insulin therapy.